Top Stories
Business
Politics
Technology
Sports
Entertainment
World
Science
Health
Ideas
Startup
Life & Culture
Africa
Asia
Australia
China
Europe
Please upgrade to premimum
subscription to use this feature.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009. ....
Be the first one to post.